Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Omdia (NASDAQ:TTGT): AI Agents Fuel Next Phase of China’s Cloud Infrastructure Expansion

Omdia, part of Informa TechTarget, Inc. (Nasdaq:TTGT), reported that mainland China’s cloud infrastructure services market returned to over 20% growth in Q2 2025, reaching USD 12.4 billion, a 21% jump compared with the previous year. This marks the first quarter since early 2024 where …

Team Kalkine | 27 November 2025

Wipro (NYSE: WIT) Secures Multi-Year Deal to Modernize Odido’s IT Systems

Wipro Limited (NYSE:WIT), one of India’s leading global technology firms, has outlined a new multi-year engagement with Odido Netherlands B.V., a key telecom provider in the Dutch market. The collaboration sets the stage for a rebuilt IT landscape that aligns with Odido’s strategic priorities …

Team Kalkine | 27 November 2025

DA Davidson Adjusts Rating Outlook for Workday (NASDAQ:WDAY)

DA Davidson issued a report on Wednesday lowering itsprice objective for Workday (NASDAQ:WDAY)fromUSD 260.00 to USD 250.00. The brokerage kept aholdrating on the software maker. DA Davidson also released its estimate forQ4 2026 earnings at USD 1.10 EPS.

Aditi Sarkar | 27 November 2025

Alphabet Inc. (NASDAQ:GOOGL): AI Momentum Drives Historic Six-Month Rally

Alphabet Inc. (NASDAQ:GOOGL) has emerged as the defining mega-cap performer of 2025, even as the broaderNasdaq-100experiences meaningfulvolatility. Since the index peaked on October 29, the 25 largest components have collectively erased nearly USD 1 trillion inmarket capitalization.

Team Kalkine | 27 November 2025

Alibaba Group (NYSE:BABA) Launches First AI Glasses in China with Quark S1 Debut

Alibaba Group Holding Ltd. (NYSE:BABA) has officially entered the smart eyewear arena with the launch of its firstAI-powered glasses, marking a notable expansion of its consumer technology portfolio. Reports indicate that the new devices, driven by Alibaba’s Qwen AI models, have already reached the …

Team Kalkine | 27 November 2025

Klarna (NYSE:KLAR) and Lufthansa Launch New Pay-Later Options for Global Travelers

Klarna Group PLC (NYSE:KLAR), a leading digital payments and lending platform, has entered a new partnership with Deutsche Lufthansa AG to broaden flexible payment solutions for air travelers around the world. Announced on November 27, 2025, the collaboration is designed to address the growing …

Team Kalkine | 27 November 2025

WeRide (NASDAQ:WRD) & Uber (NYSE:UBER): Launch of Middle East’s First Fully Driverless Robotaxi Service

WeRide Inc. (NASDAQ:WRD), a leading autonomous driving technology developer, and Uber Technologies, Inc. (NYSE:UBER) have introduced the Middle East’s first fully driverless Robotaxi service in Abu Dhabi. This launch not only elevates the region’s mobility landscape but also positions Abu Dhabi as the first …

Team Kalkine | 27 November 2025

Jacobs Solutions (NYSE:J) Teams with Arcadis for Major Faster Rail Upgrade in Queensland

Jacobs Solutions Inc. (NYSE:J) and Arcadis have been awarded a pivotal contract by the Department of Transport and Main Roads Queensland for the Logan and Gold Coast Faster Rail Project. This initiative is central to Queensland’s long-term transport vision, targeting reduced congestion, greater transit …

Team Kalkine | 27 November 2025

Ascendis Pharma (NASDAQ:ASND): Regulatory Update on TransCon CNP for Achondroplasia

Ascendis Pharma A/S (NASDAQ: ASND) reported that the U.S.Food and Drug Administrationhas extended the decision deadline for its investigational therapy, TransCon CNP (Navepegritide), by three months. The new Prescription Drug User Fee Act date is now set for February 28, 2026, instead of the …

Team Kalkine | 27 November 2025

Silexion Therapeutics (NASDAQ:SLXN) Advances SIL204 Toward Phase 2/3 Pancreatic Cancer Trial

Silexion Therapeutics Corp. (NASDAQ:SLXN) has announced an important milestone with the successful completion of toxicology studies for SIL204, a next-generation RNA-silencing therapy developed to target mutated KRAS oncogenes. Pancreatic cancer continues to be one of the deadliest malignancies, with limited treatment choices and exceptionally …

Team Kalkine | 27 November 2025
Support

Hi! How can we help you today?

Loading…